Biodesix, Inc. (BDSX) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of Biodesix, Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$27.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BDSX vs NAUT
growth of $100 · dividends reinvested · last 6yBDSX -88.7% (-30.4%/yr)NAUT -82.1% (-25.0%/yr)NAUT compounded faster over this window
BDSX NAUT
BDSX vs NAUT: by the numbers
- •BDSX is the larger company ($228M vs $225M market cap).
- •Both run net losses; BDSX's is the smaller (-26.97% vs -29747.89% net margin).
Metrics side by side
Valuation
| Metric | BDSX | NAUT |
|---|---|---|
| P/S ratio | 2.21 | 1185.48 |
| P/B ratio | 24.89 | 1.72 |
Profitability
| Metric | BDSX | NAUT |
|---|---|---|
| Gross margin | 82.50% | 0.00% |
| Operating margin | -31.37% | 0.00% |
| Net margin | -26.97% | -29747.89% |
| ROE | -303.61% | -43.11% |
| ROIC | -25.73% | -40.52% |
Growth (annualized)
| Metric | BDSX | NAUT |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | N/A |
| Total return CAGR (5Y) | -28.49% | -20.56% |
Frequently asked
- How have BDSX and NAUT total returns compared?
- Over the past 5 years, BDSX delivered -28.49% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.